| Name | Title | Contact Details |
|---|---|---|
Jeff Keating |
Chief Technology Officer | Profile |
Boston Medical Center Health Plan Inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
Next Breath is a Halethorpe, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Promises Behavioral Health is a company that provides addiction and mental health treatment at treatment facilities across the country.
Electrophoresis Equipment including Vertical Electrophoresis(Vertical Gel), Horizontal Electrophoresis(Horizontal Gels), Precast Gels, SDS Page, PCR Workstations, DNA Sequencing, and more. Products for Molecular Separations. CBS Scientific Company.